The first week is mostly about calibration: finding a strength, a hold time and a placement that your mouth tolerates, rather than working through a can as fast as you can. Start low, keep one pouch in at a time, move it around your gum rather than parking it in the same spot, and stop when you have had enough rather than when the pouch is finished. The most useful thing to know going in is that no manufacturer publishes a daily maximum, so the pacing is entirely yours to set.
This guide is for an adult who already uses nicotine and is trying pouches. I am not going to tell you that pouches are safe, because no regulator says that and I am not in a position to. The UK’s Committee on Toxicity put it plainly in its draft statement of July 2022: pouches “provide a pharmacologically active dose of nicotine in both CC smokers and nicotine-naïve users and, as such, they are not ‘harmless’ products.”
Day 1: pick a strength, and distrust the number
Start at the bottom of whatever range is available to you. In the United States that means 3 mg, which is the lowest strength on the FDA’s authorised list; elsewhere 4 mg or 6 mg is usually the floor.
Here is the thing nobody tells beginners, and it matters more in week one than at any other time: the milligram figure on the can is a poor predictor of how much nicotine you will actually get. The clearest statement of this comes from a study funded by British American Tobacco, which measured plasma nicotine across seven pouch products and reported that “Plasma nicotine concentration was not associated with the nicotine contents of the NPs.” An independent study funded by Germany’s Federal Institute for Risk Assessment found the same pattern, reporting relative bioavailability ranging from 70% to 165% across products and noting that “the pouches only contained between 80% and 90% of the declared nicotine content.”
A laboratory characterisation published in Scientific Reports in January 2026 found a 7 mg product measuring 4.6 mg and a 6 mg product measuring 5.4 mg — so a step that looks like a reduction on the label can be an increase in the mouth. If you want the full picture, we have it in mg per pouch vs mg per gram and in every brand’s strength scale compared.
The practical consequence for your first week: judge a product by what it does to you, not by what it says on the lid, and do not assume that moving to another brand at the same milligram figure is a like-for-like swap. Our first-strength guide goes further into choosing.
Day 1: where it goes, and why you should move it
Both major manufacturers describe the same placement. ZYN’s instruction is to “place one pouch between your upper lip and gum”; VELO’s is to “Take a pouch and tuck it between your upper lip and your gum,” and VELO adds that “You’ll feel a slight tingling sensation at the beginning – it is just the nicotine being released.”
What neither of them tells you is to move it. I would, and there is a reason in the dental literature. A pair of case reports published in BMC Oral Health in November 2025 described localised gingival recession and leukoplakia in two pouch users — and in both cases the lesions appeared at the exact sites where the pouches were habitually placed, with the author noting they were “consistently placed in the same buccal sites.” Those were users of 11 and 18 months’ standing, not beginners. The paper’s title says “associated with”, but its conclusions go further than that — “Nicotine pouch use may cause localized gingival recession and mucosal pathology, especially if used repeatedly in the same locations” — on two cases, with no control group. What it recommends is stopping and getting suspicious lesions examined; it does not recommend rotating placement anywhere. That part is my inference from where the lesions appeared, and it costs nothing: alternate sides, and move the pouch along the gum line rather than parking it.
Two things not to do, both from the manufacturers themselves. VELO: “VELO should not be chewed, sucked or swallowed.” ZYN: “ZYN nicotine pouches are single use only and should never be reused.” There is more detail in our guide to where exactly to put your first pouch.
Day 1: how long to keep it in
There is no single manufacturer-sanctioned answer, and the two biggest brands openly disagree. ZYN says a pouch is for “up to one hour of real nicotine satisfaction.” VELO says “You can keep your VELO under your lip for up to 30 minutes.” Both are instructions from the company that makes the product.
What the chemistry says is that most of the work happens early. COT, summarising dissolution measurements, reports that “Dissolution of nicotine was most rapid between 0 and 20 min (around 80% of release), with approximately 95% of release being achieved within 40 min.”
I would read that as licence to take a pouch out early in your first week. Be careful about one thing, though: that figure is nicotine released from the pouch, not nicotine absorbed by you. I could find no study measuring delivered plasma nicotine at different controlled hold times, so “take it out sooner to get less” is a reasonable inference from the release curve rather than something anybody has measured. Our page on how long to keep your first pouch in covers this in more depth.
Day 1: what the first hour actually does
If you are coming from cigarettes, the single most jarring difference is speed, and it is worth knowing the numbers so that you do not misread a slow onset as a dud pouch and reach for a second one.
COT’s own table of pharmacokinetic figures gives a cigarette a time-to-peak of 0.117 hours — about seven minutes — against roughly 1.0 to 1.1 hours for every nicotine pouch measured. Nicotine gum sits between them at 0.75 hours. A pouch takes something like nine times as long to reach its peak as a cigarette does.
On the physical side, BfR’s assessment recorded a median increase of 8.5 beats per minute for a 3 mg pouch and 10.5 for a 6 mg, against 11.0 for an 8 mg snus. Among reported adverse events in the studies it reviewed, 28 of 29 were minor, “with dizziness being most frequently reported, followed by nausea.” Our piece on what the first ten minutes actually feel like goes through this sensation by sensation.
Day 1: saliva
You will produce more saliva than usual and you do not need to spit. ZYN’s own answer is that “While using ZYN, you may naturally swallow saliva,” with the caveat that “the pouch itself should not be swallowed.”
Most of what you swallow is lost. The clearest statement of why comes from the Summary of Product Characteristics for a licensed nicotine lozenge, which explains that “The remaining nicotine released in the mouth is swallowed and undergoes considerable first-pass metabolism in the intestine and liver,” so that “only a small part of the total nicotine given with a lozenge reaches the circulation via the intestine.” That is a lozenge’s label, not a pouch’s — no nicotine pouch has an SmPC, because pouches are not medicines — but the pharmacology of swallowed nicotine is the same substance going the same route.
Days 2–7: find your pace, because nobody will set it for you
This is the part of the week that actually matters, and it is the part with the least guidance behind it.
I read ZYN’s and VELO’s full consumer FAQs looking for a stated maximum number of pouches per day. Neither publishes one. Neither addresses using two pouches at once. Neither says anything about keeping one in overnight. The only per-pouch ceiling published anywhere is a voluntary standard — the British Standards Institution’s PAS 8877:2022, which COT records as recommending “a maximum nicotine content of 20 mg per pouch” — and that is a limit on what may go into a pouch, not on how many you may use.
Compare that with the only regulated oral nicotine product with a published ceiling. The 4 mg nicotine lozenge’s SmPC states: “Most patients require 8 to 12 lozenges per day, not to exceed 15 lozenges.” A medicine with a licence has a number. A pouch does not.
So set your own, and set it in week one while you still have a baseline to judge against. Decide a daily count before you start the day, not after the third pouch.
The reason to take this seriously is in the medical literature. A case report in Nicotine & Tobacco Research in 2024 described a 21-year-old man who, over twelve hours, “consumed 15 extra-strength nicotine pouches (10.9 mg per pouch)” — 163.5 mg of nicotine — and presented “nauseated, somnolent, and diaphoretic.” He had been using them as a study aid. He recovered within 24 hours. The authors received no funding for the study and declare no conflicts of interest. Fifteen pouches in twelve hours is not an exotic quantity; it is roughly one an hour of a waking day.
Common mistakes in the first week
- Treating the pouch as the timer. You do not have to finish it. The release curve front-loads, so most of what you were going to get, you have already had by twenty minutes.
- Reaching for a second pouch at ten minutes. A pouch peaks at about an hour. Ten minutes in, you have not seen what it does yet.
- Parking it in the same spot every time. The documented gum lesions cluster at habitual placement sites. Move it — though, as above, that is my inference from where the lesions appeared and not an instruction anyone publishes.
- Assuming equal milligrams means equal effect across brands. The published evidence says plainly that it does not.
- Running pouches alongside your existing nicotine product without counting the total. COT is explicit that parallel use “could potentially lead to increased nicotine exposure compared with that from use of a single product-type, and may increase the overall risk of nicotine-related toxicity.” Its one qualified harm-reduction statement is conditional on exactly this: pouches “could be considered as part of a harm-reduction strategy, if their use is of lower risk than that of CC smoking and if concurrent use of other nicotine-containing products is avoided.” Both conditions, not one.
- Starting high because low “did nothing”. See the timing point above. Judge a strength after a full hour, twice.
Troubleshooting
| What you notice | What is probably happening | What I would do |
|---|---|---|
| Burning or stinging under the lip | Expected early, and partly the pouch material rather than the nicotine — BfR’s study found irritation reported across its dose range including the nicotine-free pouch | Move the pouch, shorten the hold, try a drier format. If it persists past the first few days, stop and see a dentist |
| Dizziness or nausea | The two most commonly reported minor effects in the studies BfR reviewed | Take it out. Drop a strength. Do not push through it |
| Heart noticeably faster | Documented and dose-related: BfR recorded a larger rise for a 6 mg pouch than a 3 mg | Drop a strength and shorten the hold |
| Nothing seems to happen | Most likely you are judging too early — peak is around an hour | Wait the full hour before concluding anything. Then consider that the label may under-represent this particular product |
| Sore or receding gum at one spot | Habitual placement in one site is the pattern described in the case literature | Stop using that site and see a dentist if it does not settle. Moving placement is my inference, not sourced advice |
| Wanting them much more often by day five | COT is direct that nicotine-naive users who take up pouches “would be at risk from effects of nicotine to which they would not otherwise be exposed. This includes the risk of addiction.” | Take the daily number you set at the start of the week seriously |
One clean negative worth stating, because it is the question people ask next: there is no authoritative timeline for nicotine withdrawal. I have looked across regulator documents and licensed-medicine labels over several research passes and found symptom lists with frequency categories, never an onset, peak and duration. Anyone giving you a day-by-day withdrawal chart is making it up.
If week one goes well and you want to think about where this goes next, our guide to stepping down your strength safely is the natural follow-on, and what the evidence says about quitting smoking with pouches sets out how thin the cessation evidence actually is. For the background, start with nicotine pouches explained, and for what to buy, the master ranking.
Sources
- Committee on Toxicity, draft statement on the bioavailability of nicotine from oral nicotine pouches, July 2022 (TOX/2022/38) — the “not ‘harmless'” statement, the conditional harm-reduction sentence, the dissolution figures and the PAS 8877 recommendation.
- Committee on Toxicity, statement on oral nicotine pouches, February 2023 — risk to nicotine-naive users, concurrent use.
- Committee on Toxicity, TOX/2022/22, March 2022, Table 1 — Tmax and Cmax for cigarettes, pouches, gum and snus.
- German Federal Institute for Risk Assessment, Health risk assessment of nicotine pouches, Opinion 023/2022, 7 October 2022 — heart rate, adverse events, oral irritation.
- McEwan M, Azzopardi D, Gale N, et al., Eur J Drug Metab Pharmacokinet 2022;47:211–221, doi 10.1007/s13318-021-00742-9. Funded by British American Tobacco, the manufacturer of two of the products tested; all authors but two were BAT employees.
- Mallock-Ohnesorg N, Rabenstein A, Stoll Y, et al., “Small pouches, but high nicotine doses”, Frontiers in Pharmacology 2024;15:1392027, doi 10.3389/fphar.2024.1392027. Funded by the German Federal Institute for Risk Assessment; the authors declare no commercial or financial relationships.
- Platt SP, Gonzales CM, Pokharel P, et al., “Dissolution and physical characterization of oral nicotine pouch products”, Scientific Reports 2026;16:4406, doi 10.1038/s41598-025-34556-5. No funding statement and no competing-interests statement appear on the published page; the corresponding author is at Altria Client Services LLC.
- Alkhatib OA, “Localized gingival recession and leukoplakia associated with nicotine pouch use: two clinical case reports”, BMC Oral Health 25, 28 November 2025, doi 10.1186/s12903-025-07320-4. “No external funding received”; no competing interests declared.
- Kent JT, Mok G, Austin E, “Nicotine Toxicity From Repeat Use of Nicotine Pouches”, Nicotine & Tobacco Research, 2024, doi 10.1093/ntr/ntae111. “The authors received no funding for this study”; no conflicts of interest declared.
- Nicorette Fruit 4 mg Lozenge Summary of Product Characteristics, text revised 23 June 2026.
- Manufacturer instructions read directly: ZYN and VELO, neither of which publishes a daily maximum.